INTRODUCTION
Peptidoglycan (PG) forms a protective layer around bacteria that is essential for its survival. PG is formed by linear glycan chains consisting of alternating N-acetylmuramic acid (MurNAc) and N-acetylglucosamine (GlcNAc) moieties that are crosslinked by short stem peptides. The stem peptide typically consists of the tetrapeptide L-Ala-g-D-Glu-meso-A 2 pm(or Lys)-D-Ala (A 2 pm, diaminopimelic acid), which is attached to MurNAc via a D-lactyl group. A peptide crosslink is formed between A 2 pm (or Lys) and D-Ala from adjacent glycan strands. PG is continuously degraded by cell-wall-specific lytic enzymes (van Heijenoort, 2011) , and the products are recycled (Park and Uehara, 2008) . Lytic transglycosylases (LTs) play a major role in cell-wall degradation and produce the main degradation product GlcNAc-1,6-anhydro-MurNAc-tetrapeptide (abbreviated as GlcNAcanhMurNAc-tetrapeptide hereafter, Figure 1A ). LTs catalyze cleavage of the glycosidic linkage between MurNAc and GlcNAc followed by a concomitant intramolecular transglycosylation reaction to form the 1,6-anhydro ring at the MurNAc residue of the product. Alternatively, lysozymes can hydrolyze this linkage to generate GlcNAc-MurNAc-tetrapeptide, with MurNAc in a reducing form. GlcNAc-anhMurNAc-tetrapeptide, also known as tracheal cytotoxin (TCT), plays a significant role in bacterial pathogenesis, when it escapes from the cell (Cloud-Hansen et al., 2006) .
In Escherichia coli, the GlcNAc-anhMurNAc-tetrapeptide is transported by the integral membrane transporter AmpG into the cytoplasm, where NagZ removes the N-acetylglucosamine moiety. The resulting product serves as the substrate for the amidase AmpD generating 1,6-anhydro-MurNAc and tetrapeptide. The tetrapeptide can be degraded further by the LdcA L,D-carboxypeptidase that removes the D-Ala. The MpaA zinc carboxypeptidase then removes A 2 pm from for the resulting tripeptide (Maqbool et al., 2012) and epimerase YcjG converts L-Ala-D-Glu into L-Ala-L-Glu, which is subsequently degraded by peptidase PepD. Amidases AmpD and MpaA are both metal hydrolases requiring zinc for activity ( Figure 1B ), but are not related in structure. Alternatively, the L-Ala-g-DGlu-meso-A 2 pm tripeptide can reenter the PG biosynthetic pathway via the cell wall recycling protein, murein peptide ligase (Mpl). The main PG recycling intermediate, GlcNAcanhMurNAc-tetrapeptide, and the overall degradation pathway are believed to be similar in other bacteria. However, underlying enzymes for carrying out individual steps are often not conserved. For example, Bacillus subtilis has no MpaA ortholog, but instead possesses a functionally equivalent enzyme YkfC ( Figure 1B ), an NlpC/P60 papain-like cysteine peptidase that is not related to MpaA (Xu et al., 2010) . Members of the NlpC/P60 superfamily, which often function as cell-wall hydrolases, contain a prototypical papain-like catalytic core (Anantharaman and Aravind, 2003) . We have previously determined several crystal structures of NlpC/P60 g-D-Glu-A 2 pm amidases (Xu et al., 2010 (Xu et al., , 2014 (Xu et al., , 2009 ) and other structurally related enzymes . DUF1460 defines a large protein family (>400 members) of unknown function and its members are distributed widely across the bacterial kingdom, particularly in the phyla Bacteroides ($25%) and Proteobacteria ($68%). It is classified as a member of the Peptidase_CA clan (CL0125), a large collection of proteins evolutionarily related to the papain cysteine peptidase. Two proteobacteria DUF1460 proteins are implicated in plant pathogenesis: psa9 in the pathogenicity island 2 of Pantoea stewartii subspecies stewartii DC283 (Correa et al., 2012) , and ORF2 in the exchangeable effector locus of Pseudomonas syringae pv. tomato DC3000 (Fouts et al., 2002 are annotated as xylanases in various databases, but with no supporting experimental evidence.
Structural information is of significant value in assessing protein function; however, accurate functional assignment based on structure data alone is often difficult. Here, we report a structure-based functional evaluation of DUF1460. We first determined the high-resolution crystal structure of Bacteroides uniformis AmiA, a DUF1460 family member encoded by a putative operon that is conserved in the Bacteroides genera ( Figure 1C) , as a part of our structural genomics effort to characterize the secretome of the human gut microbiome. The structure reveals that AmiA is evolutionarily related to NlpC/P60 proteins. Combining bioinformatics analysis and ligand docking, we were able to predict the protein function and its substrate specificity, which were then confirmed by biochemical characterization and cocrystal structures. Furthermore, we demonstrated that AmiA is a GlcNAc-anhMurNAc-peptide-specific N-acetylmuramoyl-L-alanine amidase. Structure-sequence analysis of the DUF1460 family members suggests a common amidase function.
RESULTS
Structure Determination of Apo AmiA and Model Quality AmiA (262 aa) from B. uniformis is a secreted protein with a predicted N-terminal signal peptide (residues 1-23). The apo AmiA structure was determined using the semiautomated, high-throughput pipeline of the Joint Center for Structural Genomics (JCSG) (Lesley et al., 2002) . The selenomethionine derivative of the mature protein (residues 24-262) was expressed in E. coli with an N-terminal, TEV-cleavable, His-tag and purified by metal affinity chromatography. The purification tag was removed prior to crystallization trials. Crystals were harvested and screened for diffraction to identify the best crystals for structure determination.
The crystal structure of apo AmiA was determined in orthorhombic space group P2 1 2 1 2 1 using the single-wavelength anomalous diffraction (SAD) method, and was refined using data to 1.15 Å resolution with an R cryst of 13.1% and an R free of 16.4%. The asymmetric unit (asu) contains one monomer and 431 water molecules. Backbone conformations for all residues were within the allowed region of the Ramachandran plot, and 98.2% in the most favorable regions. The electron density was well defined for most residues except for a short disordered loop (residues 80-83), which was not included in the final model. The high-resolution maps also allowed modeling of multiple conformations for 22.5% of the residues. The quality of the final model (PDB ID 4H4J) compares favorably to other structures with similar resolutions, with an overall MolProbity score ) that ranks in the 93 rd percentile. A summary of data collection, processing, and refinement statistics is provided in Table 1 .
AmiA Is Evolutionarily Related to NlpC/P60 Proteins Analytical size-exclusion chromatography indicates that AmiA is a monomer in solution (data not shown), which is consistent with the lack of extensive intermolecular packing interfaces in the crystal lattice. The AmiA monomer has an a/b/a three-layered sandwich fold. The catalytic core consists of a central fivestranded b sheet and four a helices with a topology of a1-a2-a3-b1-b2-b3-b4-a4-b5, which most closely resembles that of 
where CC(1/2) values for < I > are calculated by splitting the data randomly in half; R cryst = Sj jF obs j À jF calc j j/SjF obs j, where F calc and F obs are the calculated and observed structure factor amplitudes, respectively; and R free = as for R cryst , but for 5.0% of the total reflections chosen at random and omitted from refinement. 
Structure
Structure of an NlpC/P60 Amidase the NlpC/P60 g-D-Glu-A 2 pm amidase ( Figure 2A ). For example, AmiA can be superimposed onto the NlpC/P60 domain of Clostridium difficile CwlT (PDB ID 4HPE), a bifunctional cellwall hydrolase whose structure we recently determined (Xu et al., 2014) , with a root-mean-square deviation (rmsd) of 2.8 Å and sequence identity of 19% for 119 equivalent Ca atoms. Compared to a prototypical NlpC/P60 domain, such as CwlT, AmiA contains three insertions: insert 1 between a1 and a2 (residues 44-60), insert 2 between a2 and a3 (residues 84-111), and insert 3 between a3 and b1 (residues 124-193) ( Figure 2A ). Insert 3 is the longest ($70 aa) and is stabilized by extensive interactions with the core domain. All three inserts converge on one side of AmiA and contribute to the formation of a large pocket aside the catalytic cysteine (Cys63). The catalytic triad Cys63/His212/His227 and a nearby Tyr41, which presumably functions to stabilize the reaction intermediate (Xu et al., 2009) , are identical to those in CwlT ( Figure 2B ) and other NlpC/P60 enzymes (Xu et al., 2009 (Xu et al., , 2010 (Xu et al., , 2014 . Two discrete conformations of the active site residues, Tyr41 and Cys63, are observed in the electron density (Figure 2B) . The catalytic Cys63 is located on the N terminus of a2, which is a common characteristic of the papain superfamily of enzymes. A feature of NlpC/P60 proteins is the frequent substitution of the third polar residue of the catalytic triad by a histidine, rather than asparagine or glutamine as is typical of other papain-related peptidases. AmiA also shares this feature (His227). Thus, AmiA appears to share the same ancestral origin as NlpC/P60 g-D-Glu-A 2 pm amidases.
Computational Prediction of AmiA Function
Based on the above analysis and on its homology to NlpC/P60 proteins, we inferred that AmiA might be a cysteine hydrolase, but its specific substrate was unknown. To identify potential substrates, we examined the genetic context of DUF1460 family members since functionally associated genes are often clustered together as operons in bacteria. In Bacteroides genomes, DUF1460 genes are often proximal to genes encoding an oligopeptide transporter and another a/b hydrolase ( Figure 1C ). More intriguingly in Mycobacterium sp. and Fibrobacter succinogenes, the DUF1460 domain is fused to either an LT (UniProt: Q1B6F7_MYCSS) or a D-alanyl-D-alanine carboxypeptidase (UniProt: C9RRN1_FIBSS), suggesting that DUF1460 is likely to cooperate with these two enzyme activities at the substrate level. These clues suggest that DUF1460 members may be involved in the degradation of PG and generation of oligopeptides, consistent with the role of NlpC/P60 enzymes as cell-wall hydrolases.
The active site ( Figure 2C ) is composed of a large deep pocket on one side of the active site Cys63 (referred to as Structure Structure of an NlpC/P60 Amidase the nonprime side, borrowing the terminology for peptidases) and a shallow groove on the other side (prime side), which would complement the shape of saccharide-peptide PG fragments (a large head connected to a thin tail, Figure 1A ). To identify the best possible substrates for AmiA, we fitted various PG fragments into the active site using in silico docking. We started by docking mono-and disaccharides (GlcNAc, MurNAc, GlcNAc-anhMurNAc, and GlcNAc-MurNAc) into the nonprime side pocket to access its relative size. This modeling process suggested that the pocket could best accommodate two saccharide moieties. Next, we tested docking of representative peptide-linked disaccharides (GlcNAc-MurNAc-L-Ala, GlcNAc-anhMurNAc-tripeptide, and GlcNAc-MurNAc-tripeptide). The best docking solution was selected by visual inspection from top-scored poses to best satisfy: (1) shape complementarity between ligand and pocket, i.e., saccharides filling the large pocket on the nonprime side along with fitting of the stem peptide into the groove on the prime side; (2) presence of a substrate carbonyl group near Tyr41 so that the tyrosine can fulfill its role in stabilizing the reaction intermediate; and (3) favorable interactions between protein and ligand (including van der Waals contacts and hydrogen bonds). Overall, we concluded that the active site of AmiA could best accommodate the GlcNAc-anhMurNAc-tripeptide ( Figure 2D ).
The lactic acid-L-Ala linkage is located above the catalytic cysteine, suggesting that AmiA is an N-acetylmuramoyl-Lalanine amidase.
Enzymatic Activity and Substrate Specificity The activity of AmiA was then tested on different PG precursors as well as on various characteristic PG fragments (muropeptides) that are known to be released by hydrolases during cell growth and division and subsequently recycled for de novo PG synthesis. The main cell-wall degradation product, GlcNAc-anhMurNAc-L-Ala-g-D-Glu-meso-A 2 pm-D-Ala (TCT), was readily hydrolyzed by AmiA (Figure 3 ). High-performance liquid chromatography (HPLC) analysis of the reaction mixture unambiguously identified GlcNAc-anhMurNAc and tetrapeptide as the two reaction products. Thus, AmiA clearly exhibited N-acetylmuramoyl-L-alanine amidase-type activity. We estimated the K m value for TCT to be 16 mM. Inhibition of the enzyme by excess of substrate was observed for substrate concentrations higher than 0.2-0.4 mM.
Consistent with the involvement of an essential nucleophilic cysteine residue in the catalytic process, the AmiA activity was dramatically affected by thiol reagents. Activity was totally abolished following preincubation of AmiA for 5 min with 60 mM 2,4-dinitrothiocyanobenzene (DTNB) and p-hydroxymercuribenzoate (pHMB), and was decreased by 60% and 85% with 2-nitro-5-thiocyanobenzoic acid (NTCB) and N-ethylmaleimide (NEM), respectively. Iodoacetamide, however, had no detectable inhibitory effect in the same assay conditions. Neither MgCl 2 (2.5 mM) nor EDTA (5 mM) showed any effect on the enzyme activity.
The substrate specificity of this enzyme was then analyzed by incubating AmiA with a panel of other compounds, including PG precursors, muropeptides, and the polymer itself. In a first series of assays that used a high amount of AmiA (1 ml of undiluted stock, i.e., 20 mg of protein per assay), total hydrolysis was observed for the GlcNAc-anhMurNAc-L-Ala-D-Glu, GlcNAcanhMurNAc-L-Ala-g-D-Glu-meso-A 2 pm, TCT-dimer (two TCT crosslinked via their tetrapeptide chains), GlcNAc-MurNActetrapeptide and its dimer. AmiA did not exhibit any activity toward any other tested compounds, in particular anhMurNActetrapeptide and MurNAc-tetrapeptide (Table 2 ). These results indicated that AmiA absolutely required the presence of a disaccharide but accepted either a MurNAc or anhMurNAc moiety at the second position of the disaccharide, as well as di-, tri-, and tetrapeptide chains.
The specific activity of AmiA for all its identified substrates was then precisely determined in the same assay conditions but with appropriate enzyme dilutions ( Table 2 ). The activity of AmiA toward TCT was estimated at 8,500 nmol/min/mg, as compared to only 1.4 nmol/min/mg for the non-anhydro GlcNAc-MurNAc-tetrapeptide, with the same trend for the corresponding peptide dimers. The length of the stem peptide (di-, tri-, or tetrapeptide) did not affect significantly the AmiA activity, but a slight preference (2-fold increased activity) for the dipeptide was observed (Table 2) . Overall, we conclude that AmiA is an N-acetylmuramoyl-L-alanine amidase that is not active toward intact PG but exhibits a high activity and specificity toward GlcNAc-anhMurNAc-peptides (monomer and dimer forms) derived from the PG polymer. were analyzed by HPLC on a column of Nucleosyl 100 5 m C18. Elution was performed at 0.6 ml/min with 50 mM sodium phosphate, pH 4.5, and a linear gradient of MeOH from 0 to 25% applied over 60 min. Peaks were detected at 207 nm. Both TCT and TCT dimer were cleaved, generating in each case two products that were identified as tetrapeptide and GlcNAc-anhMurNAc, and octapeptide and GlcNAc-anhMurNAc, respectively, consistent with an Nacetylmuramoyl-L-alanine amidase activity of AmiA.
Structural Basis for Substrate Specificity Docking of the GlcNAc-anhMurNAc-tripeptide substrate into our crystal structure along with biochemical analysis suggest that the nonprime side binding sites play a more significant role in substrate specificity. To understand the structural basis for substrate specificity, we determined cocrystal structures of AmiA with GlcNAc (PDB ID 4Q68) and GlcNAc-anhMurNAc (a reaction product, PDB ID 4Q5K). AmiA-GlcNAc complex crystallized in the same crystal form as apo AmiA with only small changes of the unit cell, whereas the AmiA-GlcNAc-anhMurNAc complex crystallized in the same space group but in a different crystal form. Both complex crystals diffracted to high resolution (1.07 Å and 1.3 Å , respectively), and the data and the final models are of similar quality to that of the apo AmiA structure ( Table 1) . As expected, these structures are very similar to that of the apo protein (rmsds < 0.5 Å for all Ca atoms). GlcNAc was bound to AmiA but with an occupancy of $0.5 ( Figure 4A ), while GlcNAc-anhMurNAc fully occupied the binding site of AmiA ( Figure 4B ), suggesting that the disaccharide may have higher binding affinity than GlcNAc alone. In each case, the quality of electron density for the ligands was excellent and allowed unambiguous identification of the mode of sugar recognition. As expected, the GlcNAc-anhMurNAc saccharide occupied the nonprime pocket. GlcNAc and anhMurNAc moieties had a $90 difference in their orientation. GlcNAc was stabilized by extensive hydrogen bonding interactions, while anhMurNAc did not form any specific polar interactions with AmiA except for one hydrogen bond between the lactic acid group and Tyr41OH ( Figures 4C and 4D ). The conformation of GlcNAc moiety in both complexes was identical and sandwiched between His111 and the a2 helix carrying the catalytic Cys63. The side chains of Asp62, Arg109, and His111 formed hydrogen bonds with 6-OH, 4-OH, and 3-OH of GlcNAc, respectively. The N-acetyl amine group of GlcNAc was stabilized by hydrogen bonds with His111O (carbonyl) and Tyr152OH. These observations are consistent with the requirement of GlcNAc for enzyme activity. The GlcNAc-anhMurNAc structure explains why GlcNAc-MurNAc-peptide is a poor substrate for AmiA. The sugar moiety of anhMurNAc was located in a small hydrophobic pocket formed by Thr64, Ile113, Met213, Val210, and Ala211, which is sterically and chemically unfavorable to accommodate the polar groups of 1-OH and 6-OH of MurNAc. In our modeled complex ( Figure 2D ), the saccharides occupied the same locations but were $90 rotated compared to the crystal structures ( Figure 4 ). Although it is challenging to computationally predict accurate poses for large, flexible substrates, in this case, we were able to correctly predict substrate identities by narrowing down possible substrates significantly via bioinformatics analysis, and exploring differences among substrates (e.g., one sugar versus two sugars, MurNAc versus anhMurNAc) via docking.
The structural data above suggested that GlcNAc or GlcNAcanhMurNAc may inhibit the activity of AmiA. Using TCT as a substrate, we tested the activity of AmiA in the presence of excess GlcNAc, MurNAc, or GlcNAc-anhMurNAc. AmiA retained 15%, 25%, and 98% of its activity at 1 mM GlcNAc-anhMurNAc, MurNAc, and GlcNAc, respectively. At 5 mM inhibitor, >85% of AmiA activity was inhibited by MurNAc, while only $8% was inhibited by GlcNAc. Thus, the disaccharide is a more efficient inhibitor than MurNAc or GlcNAc, while MurNAc is also a good inhibitor compared to GlcNAc. Modeling studies suggest that MurNAc can bind AmiA in the same manner as GlcNAc, except that the lactic acid group of MurNAc might increase the binding affinity by forming additional contacts with the protein, compared to that of GlcNAc.
DUF1460 Defines an Amidase Family
The insights derived from our AmiA structural and functional studies can be applied to other members of DUF1460, such as the two structures previously determined by structural genomics efforts, BF2036 and LPG0654. BF2036 is almost identical to AmiA in overall structure (rmsd of only 0.8 Å with sequence identity of 67% for 228 equivalent Ca atoms). LPG0654 is significantly more divergent in sequence and 95 aa longer than AmiA. However, its overall structure is still similar to that of AmiA (rmsd of 2.4 Å and sequence identity of 27% for 219 equivalent Ca atoms). The most significant differences are located in insert or loop regions, such as insert 3, insert 1, and the b1-b2 loop. LPG0654 also has an additional N-terminal helix. However, these structural differences do not impact the active site of BF2036 and LPG0654, which are highly conserved ( Figures 5A and 5B). The conformation of the substrate disaccharide in the AmiA structure fits well into the active sites of both BF2036 and LPG0654 (Figures 5A and 5B ). Most notably, the residues involved in GlcNAc binding are strictly conserved in these three proteins as well as in other DUF1460 members ( Figure 5C ). One side of the saccharide-binding pocket mainly consists of catalytic residues with a DCXT+H+H/N/Q+Y motif (where X is GlcNAc-anhMurNActripeptide
GlcNAc-anhMurNAcdipeptide + 18,600
Dimer of TCT + 10,500
AnhMurNAc-tetrapeptide À GlcNAc-MurNAc-tetrapeptide + 1.4
Dimer of GlcNAc-MurNActetrapeptide
Peptidoglycan À a Minus and plus indicate ''undetected'' (below the limitations of the analytical method used; <2% substrate transformation, specific activity < 0.2 nmol/min/mg) and ''complete substrate transformation,'' respectively, when 1 ml of undiluted stock of AmiA, i.e., 20 mg of protein, was used per assay. b Determined as described in Experimental Procedures using appropriate dilutions of enzyme and substrate concentrations of 0.2 mM.
Structure
Structure of an NlpC/P60 Amidase any amino acid), while the other side is anchored by an RXH motif (Arg105 and His107 of BF2036, Arg156 and His158 of LPG0654, Figure 5 ). The arginine side chain in the RXH motif is stabilized by one or more acidic residues, while Nε2 of the histidine hydrogen bonds with a main-chain carbonyl group (Tyr102 of BF2036 and Tyr153 of LPG0654) to orient Nd1 toward the pocket. Thus, these observations suggest that DUF1460 likely consists of a family of amidases with similar substrate specificities despite significant sequence divergence.
DISCUSSION
In the GlcNAc-anhMurNAc complex structure, the carboxylate carbon atom of the lactic acid is located above Cys63 (distance to Sg 3.58 Å , Figure 4B ). This model is consistent with a papain cysteine peptidase-like mechanism (Storer and Mé nard, 1994; Xu et al., 2009) for AmiA where the thiol group of Cys63 is de- protonated by the polarizing imidazole group of His212 to form a nucleophilic thiolate/imidazolium ion pair, and the thiolate anion then attacks the carbonyl carbon of the amide scissile bond of the substrate to form a tetrahedral intermediate. The transition state is stabilized by an oxyanion hole that may consist of the hydroxyl group of Tyr41, and potentially the helix dipole of a2 and the carbonyl group of Ala211. His212 then acts as a general acid and protonates the nitrogen in the amide bond, resulting in release of the stem peptide and concomitant formation of the acylenzyme intermediate. His212 abstracts a proton from a water molecule while it attacks the carbonyl carbon, forming a second oxyanion hole-stabilized tetrahedral intermediate, which then decomposes with the Cys63 sulfur functioning as a leaving group, releasing GlcNAcanhMurNAc and regenerating the active enzyme. PG fragments mediate a range of microbial-host interactions (Cloud-Hansen et al., 2006) . As a result, studying PG fragments released by human pathogens and symbionts are of great biological interest. GlcNAc-anhMurNAc-tetrapeptide is a cytotoxin and a potent elicitor of innate immune responses. However, little is currently known about the production and recycling of PG fragments other than in a few bacteria. Here, we identified a highly specific gut bacterium amidase involved in the degradation of GlcNAc-anhMurNAc-peptide. The clustering of functionally related genes in Bacteroides ( Figure 1B) suggests another pathway for GlcNAc-anhMurNAc-peptide degradation and recycling, in which AmiA, likely located in periplasm, hydrolyzes GlcNAc-anhMurNAc-peptide into a disaccharide and stem peptide. The stem peptide may be further hydrolyzed by an a/b hydrolase (e.g., by removing a D-Ala) and other enzymes, resulting in smaller peptides that are eventually transported by the oligopeptide permease into the cell where they can be further
Structure
Structure of an NlpC/P60 Amidase degraded or recycled. This proposed pathway differs from that in E. coli, where GlcNAc-anhMurNAc-peptide is degraded in the cytoplasm by NagZ and then AmpD. Although AmiA and AmpD cleave the same bond, they differ in substrate specificities: AmpD can use both GlcNAc-anhMurNAc-peptide and anhMurNAc-peptide equally well and, thus, does not have specificity for the GlcNAc moiety (Jacobs et al., 1995) , whereas AmiA absolutely requires the GlcNAc moiety for its function. AmpD is a zinc-dependent amidase in the amidase_2 family and, hence, is not related to AmiA in sequence and structure. Thus, AmpD and AmiA represent another example of independent evolution of amidases from a zinc peptidase or cysteine peptidase (NlpC/P60) ancestor, respectively, similar to that of MpaA and YkfC ( Figure 1B ). Our study of AmiA reinforces the notion that bacteria have evolved more diverse systems for PG recycling, in contrast to the highly conserved PG biosynthesis pathway.
Our structure analysis established that DUF1460 is most closely related to the NlpC/P60 g-D-Glu-A 2 pm amidases. NlpC/P60 amidases have broad-spectrum substrate specificity. Prototypical NlpC/P60 enzymes often have broader substrate specificity and are able to cleave any PG, while NlpC/P60 enzymes with more complex architectures, evolved from structural adaptions of the same fold, are more specific and cleave only certain types of PG fragments. Our structural studies identified two modes of such structural adaptations. For the g-D-Glu-A 2 pm YkfC amidase, an N-terminal bacterial SH3 domain was attached to the nonprime side of the active site groove, thereby restricting access to stem peptides with a free L-alanine (Xu et al., 2010 (Xu et al., , 2009 ). For AmiA described here, the substrate specificity was achieved through several insertions within the scaffold. In both cases, however, the structural adaptions resulted in modifications of the nonprime binding sites. These highly specific enzymes have evolved with the specific purpose of salvaging PG components, while avoiding the negative consequences of comprising the integrity of the cell wall or disrupting the biosynthesis of PG.
DUFs account for more than 20% of all protein domains, and many of them have important biological functions (Goodacre et al., 2013) . Identifying the function of DUFs aids in uncovering unexpected similarities to other characterized proteins or identifying novel biological processes and reactions, thereby promoting new frontiers of biological discovery. Structural genomics efforts have contributed a large number of DUF protein structures. However, it remains a significant challenge to leverage this enormous wealth of structural information and achieve a better understanding of their molecular function. Here, we have applied a structure-driven, combined approach to uncover the function of DUF1460. The structural data were indispensable in revealing the relationship with NlpC/P60 proteins, and provided a platform for virtual screening of potential substrates, which significantly reduced the number of biochemical experiments to validate our functional hypotheses. We expect this approach also can be applied to understand the structure and function of other DUFs and accelerate the discovery of new and unexpected biological activities.
Structure of an NlpC/P60 Amidase EXPERIMENTAL PROCEDURES Protein Production AmiA was cloned, expressed, and purified using a protocol similar to that reported previously for CwlT (Xu et al., 2014 ) (see Supplemental Experimental Procedures). The purified protein was concentrated to 20 mg/ml (0.75 mM) by centrifugal ultrafiltration (Millipore) for crystallization trials or biochemical characterizations.
Crystallization Apo AmiA was crystallized using the nanodroplet vapor diffusion method (Santarsiero et al., 2002) with standard JCSG crystallization protocols (Lesley et al., 2002) . Sitting drops composed of 100 nl protein solution mixed with 100 nl crystallization solution in a sitting drop format were equilibrated against a 35 ml reservoir at 277 K for 29 days prior to harvest. The crystallization reagent consisted of 30% polyethylene glycol (PEG) 1500. PEG 200 was added to a final concentration of 10% (v/v) as a cryoprotectant. Initial screening for diffraction was carried out using the Stanford Automated Mounting (SAM) system (Cohen et al., 2002) at the Stanford Synchrotron Radiation Lightsource (SSRL). Apo AmiA diffraction data were indexed in orthorhombic space group P2 1 2 1 2 1 with unit cell a = 46.3, b = 63.7, and c = 73.0 Å .
Crystals of the AmiA-ligand complexes were obtained by cocrystallization using the hanging drop method at 277 K. The hanging drops contained 1 ml protein solution mixed with 1 ml reservoir solution. For AmiA-GlcNAc, 1.3 mM GlcNAc was added to the reservoir (250 ml) containing 30% PEG 1500. For the AmiA-GlcNAc-anhMurNAc, 0.93 mM of GlcNAc-anhMurNAc was added to the protein solution, and the reservoir (500 ml) contained 29% PEG 4000 and 0.1 M Tris, pH 8.5. No cryoprotectant was added. The AmiA-GlcNAc diffraction data were indexed in the same space group as the apo AmiA with only small changes in the unit cell (a = 46.5, b = 63.6, and c = 74.0 Å ). AmiA-GlcNAc-anhMurNAc crystals had the same space group but exhibited differences in the unit cell dimensions (a = 49.5, b = 60.9, and c = 80.1 Å ).
Data Collection, Structure Solution, and Refinement SAD data for apo AmiA were collected at the selenium edge using a Pilatus 6M detector (DECTRIS) at SSRL beamline BL12-2. Single-wavelength data were collected for the AmiA-GlcNAc-anhMurNAc and AmiA-GlcNAc complexes using MarCCD325 detector (Rayonix) at SSRL beamline 14-1. Data processing and structure solution were carried out using the automated structure determination protocols developed at the JCSG (van den Bedem et al., 2011; Xu et al., 2010) . The data were processed using XDS (Kabsch, 2010) . The apo structure was determined using the SAD method, where the location of selenium sites, initial phasing, and identification of the space group were carried out using SHELXD (Sheldrick, 2008 ). Phase refinement and initial model building were performed using autoSHARP (Bricogne et al., 2003) and ARP/wARP (Langer et al., 2008) . The AmiA-GlcNAc-anhMurNAc and AmiAGlcNAc complex structures were solved by the molecular replacement method implemented in MOLREP (Vagin and Teplyakov, 2010) using the apo structure as a template. Model completion and refinement were performed manually with COOT (Emsley and Cowtan, 2004) and REFMAC5 (Murshudov et al., 2011) . All refinements included anisotropic temperature factors and, for the apo structure, experimental phase restraints in the form of Hendrickson-Lattman coefficients. Molecular graphics were prepared with PyMOL (Schrö dinger).
Bioinformatics and Molecular Modeling
Protein family information for DUF1460 and domain architectures were obtained from Pfam (Punta et al., 2012) . Genomic context was studied using KEGG (Ogata et al., 1999) . Initial conformations of various ligands in random orientations were obtained from the PDB or generated using ChemBioOffice (CambridgeSoft) or JLigand (Lebedev et al., 2012) of CCP4 and COOT (Emsley and Cowtan, 2004) . Flexible ligand docking was performed with AutoDock Vina (Trott and Olson, 2010) and Glide (Schrö dinger) to generate a list of poses with highest scores. The final solutions were obtained by visual inspection to satisfy geometrical and chemical restraints, manual adjustments in COOT to fine-tune local interactions, and then energy minimization.
Activity Assays
The AmiA activity assay consisted of monitoring the hydrolysis of PG-related compounds in a reaction mixture (50 ml) containing 50 mM Tris-HCl, pH 7.8, 0.2 mM substrate, and purified AmiA enzyme. One microliter of the protein stock (i.e., 20 mg of AmiA protein) was used first in preliminary assays aimed at identifying compounds that were or were not substrates of this enzyme. Subsequent assays aimed at precisely determining the specific activity of AmiA for these substrates used appropriately adjusted amounts of enzyme (from 5 ng to 2 mg; protein dilutions being performed in 20 mM potassium phosphate buffer, pH 8). After 30 min of incubation at 37 C, reactions were stopped by flash freezing in liquid nitrogen. In each case, the substrate and reaction products were separated by HPLC, using appropriate column and elution conditions. For all tested compounds, a Nucleosyl 100 5 m C 18 column (250 3 4.6 mm, Alltech France) was used and elution was with 50 mM sodium phosphate, pH 4.5, with or without application of a linear gradient of MeOH (from 0 to 25%) between 0 and 60 min, at a flow rate of 0.6 ml/min. Peaks were detected by measuring the absorbance at 262 nm (nucleotide PG precursors) or 207 nm (other compounds). Retention times of AmiA substrates and products observed in these HPLC conditions are reported in Table S1 (available online, related to Table 2 ). Identification of these compounds was based on their retention time compared to authentic standards as well as on their amino acid and amino sugar composition determined with a Hitachi model L8800 analyzer (ScienceTec) after hydrolysis of samples in 6 M HCl at 95 C for 16 hr. For determination of the K m for TCT, the same assay was used at various concentrations of this substrate in the 2-400 mM range and 1.3 ng of enzyme per assay.
Inhibition of AmiA Activity AmiA (0.75 mM) was preincubated for 5 min at 37 C with various thiol reagents (DTNB, NTCB, pHMB, iodoacetamide, and NEM) at a 60 mM final concentration in 20 mM potassium phosphate buffer, pH 7.4. Then, 2 ml aliquots of these mixtures were added to 50 ml standard assay reaction mixtures containing GlcNAc-anhMurNAc-tetrapeptide (TCT) as the substrate. After 30 min of incubation at 37 C, reactions were stopped and mixtures were analyzed by HPLC, as described above. The inhibitory effects of GlcNAc and MurNAc at 1 and 5 mM, and GlcNAc-anhMurNAc at 0.3 and 1 mM were tested using 0.1 mM of TCT as substrate.
PG Precursors and Muropeptides
UDP-MurNAc-peptides were generated as described previously (Flouret et al., 1981) and their MurNAc-peptides derivatives were obtained by mild acid hydrolysis (0.1 M HCl, 100 C, 30 min) (Hervé et al., 2007) . Lactoyl-pentapeptide and free pentapeptide were produced by treatment of MurNAc-L-Ala-g-DGlu-meso-A 2 pm-D-Ala-D-Ala with 4 M ammonium hydroxide (Stenbak et al., 2004) and E. coli AmiD N-acetylmuramoyl-L-alanine amidase (Pennartz et al., 2009) , respectively. PG was purified from an E. coli Dlpp mutant strain that does not express the Lpp lipoprotein (Leulier et al., 2003) . GlcNAc-anhMurNAc-L-Ala-g-D-Glu-meso-A 2 pm-D-Ala (TCT) and its dimer were produced by digestion of PG with E. coli SltY LT (Stenbak et al., 2004) . The TCT derivative carrying only a L-Ala-g-D-Glu-meso -A 2 pm tripeptide chain was produced by treatment of TCT with LdcA L,D-carboxypeptidase (Das et al., 2013) , and the TCT derivative carrying a L-Ala-g-D-Glu side chain was generated by treatment of TCT with a g-D-Glu-A 2 pm amidase activity purified from Desulfovibrio vulgaris (data not shown). AnhMurNAc-tetrapeptide was produced by treatment of TCT with E. coli NagZ b-N-acetylglucosaminidase (Stenbak et al., 2004) . GlcNAc-MurNAc-tetrapeptide and its dimer were generated by treatment of PG with muramidase (mutanolysin, Sigma) (Stenbak et al., 2004) . GlcNAc-anhMurNAc was prepared by cleaving TCT with pure B. uniformis AmiA activity. All these compounds were purified by HPLC and their composition was controlled by amino acid and amino sugar content analysis and/or by MALDI-TOF mass spectrometry.
ACCESSION NUMBERS
The structure factors and atomic coordinates are deposited in the RCSB Protein Data Bank (http://www.rcsb.org) with accession numbers 4H4J (apo AmiA), 4Q68 (AmiA-GlcNAc), and 4Q5K (AmiA-GlcNAc-anhMurNAc). The plasmid was deposited in PSI:Biology-Materials Repository (https://dnasu. org/DNASU/) with clone ID BuCD00332345. 
